Annovis Bio Inc
NYSE:ANVS
Annovis Bio Inc
NYSE:ANVS
Price:
2.03
USD
-5.58%
Market Closed
Market Cap:
$53.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Annovis Bio Inc
NYSE:ANVS
|
US |
|
V
|
Vinacomin Ha Lam Coal JSC
VN:HLC
|
VN |
|
P
|
Perak Corporation Bhd
KLSE:PRKCORP
|
MY |
|
S
|
SMC Global Securities Ltd
BSE:543263
|
IN |
|
Edimax Technology Co Ltd
TWSE:3047
|
TW |
|
Kalray SA
PAR:ALKAL
|
FR |
|
Z
|
Zhonglu Co Ltd
SSE:600818
|
CN |
Balance Sheet
Balance Sheet Decomposition
Annovis Bio Inc
Annovis Bio Inc
Balance Sheet Decomposition is not available for
Annovis Bio Inc
Annovis Bio Inc
Balance Sheet
Annovis Bio Inc
Annovis Bio Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
8
|
46
|
28
|
6
|
11
|
20
|
|
| Cash Equivalents |
0
|
0
|
0
|
8
|
46
|
28
|
6
|
11
|
20
|
|
| Total Receivables |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
8
|
4
|
3
|
2
|
|
| Total Current Assets |
0
|
0
|
1
|
8
|
46
|
36
|
10
|
14
|
21
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
-86%
|
1
+2 140%
|
8
+625%
|
46
+467%
|
36
-22%
|
10
-72%
|
14
+36%
|
21
+51%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
0
|
1
|
0
|
1
|
4
|
1
|
2
|
3
|
|
| Accrued Liabilities |
0
|
1
|
1
|
0
|
1
|
4
|
3
|
2
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
1
|
2
|
1
|
2
|
8
|
4
|
4
|
4
|
|
| Long-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
14
|
1
|
1
|
|
| Total Liabilities |
0
N/A
|
1
+16%
|
3
+360%
|
1
-78%
|
2
+160%
|
8
+410%
|
18
+133%
|
5
-74%
|
4
-8%
|
|
| Equity | ||||||||||
| Common Stock |
7
|
7
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
7
|
8
|
9
|
14
|
29
|
54
|
110
|
135
|
164
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
22
|
73
|
82
|
103
|
144
|
181
|
|
| Total Equity |
0
N/A
|
1
-300%
|
2
-188%
|
8
N/A
|
44
+490%
|
28
-36%
|
8
N/A
|
9
N/A
|
17
+81%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
-86%
|
1
+2 140%
|
8
+625%
|
46
+467%
|
36
-22%
|
10
-72%
|
14
+36%
|
21
+51%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
6
|
6
|
7
|
7
|
8
|
8
|
11
|
14
|
27
|
|
Switch to:
Switch to:
See Also
Discover More
